Uğur Şahin
 | This article or section is in a state of significant expansion or restructuring. You are welcome to assist in its construction by editing it as well. If this article or section has not been edited in several days, please remove this template. If you are the editor who added this template and you are actively editing, please be sure to replace this template with {{in use}} during the active editing session. Click on the link for template parameters to use.
This article was last edited by 132.62.88.128 (talk | contribs) 3 years ago. (Update timer) |
Uğur Şahin (Turkish: [u.ˈuɾ ʃɑ.ˈhin]; born 1965) is a Turkish-born German[1][2] immunologist and physician. He is a professor of oncology at the University of Mainz and the chief executive and co-founder of biotech company BioNTech.[3][4][5][6]
Early life and education
Şahin was born in Iskenderun, Turkey. When he was four years old his family immigrated to Germany, where his father worked in a Ford car factory.[7] He studied medicine at the University of Cologne, graduating in 1990, and obtained a PhD from the same university in 1993. Following an eight-year residency at the Saarland University Hospital, he joined the faculty of the University of Mainz in 2000, where he became a professor in 2006.[8]
Career
In addition to his role as a professor and practicing physician at the University of Mainz Hospital, Şahin has founded or been involved in numerous companies over the course of his career. In 2001 he founded Ganymed Pharmaceuticals, which developed cancer immunotherapies[9] and was purchased by Astellas Pharma in 2016.[10]
He shared the 2019 [[Mustafa Prize] with Ali Khademhosseini.
Personal life
He married his wife, Özlem Türeci, who is also a Turkish-German physician and immunologist, in 2002. They have one teenage daughter together.[11]
References
- ^ "Coronavirus: The married couple behind the successful Pfizer COVID vaccine". Sky News. Retrieved 2020-11-10.
- ^ Oltermann, Philip (2020-11-09). "BioNTech's Covid vaccine: a shot in the arm for Germany's Turkish community". The Guardian. ISSN 0261-3077. Retrieved 2020-11-10.
- ^ "Covid vaccine: First 'milestone' vaccine offers 90% protection". November 9, 2020 – via www.bbc.co.uk.
- ^ "Leadership". BioNTech.
- ^ "Ugur Sahin (0000-0003-0363-1564)". orcid.org.
- ^ Vardi, Nathan. "Ugur Sahin Becomes A Billionaire On Hopes For Technology Behind COVID-19 Vaccine". Forbes.
- ^ Huggler, Justin. "German couple behind vaccine are immigrant success story". The Telegraph. Retrieved 9 November 2020.
- ^ "CV Prof. Dr. med. Ugur Sahin". SFB 1399 Mechanisms of Drug Sensitivity and Resistance in Small Cell Lung Cancer.
- ^ "Astellas Completes Acquisition of Ganymed Pharmaceuticals". Astellas.com. Retrieved 9 November 2020.
- ^ Wright, Rob (1 June 2020). "How One Professor Built Two Billion-Dollar Biotechs". Life Science Leader. Retrieved 9 November 2020.
- ^ Oltermann, Philip (2020-11-09). "BioNTech's Covid vaccine: a shot in the arm for Germany's Turkish community". The Guardian. ISSN 0261-3077. Retrieved 2020-11-10.
External Links
 | This German business-related biographical article is a stub. You can help Wikipedia by expanding it. |
- 1965 births
- Living people
- Saarland University alumni
- University of Cologne alumni
- German academics
- German physicians
- German billionaires
- German chief executives
- German people of Turkish descent
- Turkish academics
- Turkish physicians
- Turkish emigrants to Germany
- Turkish billionaires
- Turkish chief executives
- German business biography stubs